Evidence map›Paper›PMID 2447967›Full record

ArticleBiophysical journal1987

Diffusion of dihydropyridine calcium channel antagonists in cardiac sarcolemmal lipid multibilayers.

D W Chester, L G Herbette, R P Mason, A F Joslyn, D J Triggle, D E Koppel

Open access · greenAbstract read
In one paragraph

Article in Biophysical journal, 1987. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 80 citations in OpenAlex.

  1. Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2015
    Article
  2. Review
  3. Ligands, their receptors and ... plasma membranes.Molecular and cellular endocrinology · 2009
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

D W ChesterDepartment of Medicine, Department of Radiology, University of Connecticut Health Center, Farmington 06032.
L G Herbette
R P Mason
A F Joslyn
D J Triggle
D E Koppel
UConn Health · US

Funding

X-RAY DIFFRACTION COREP01HL033026 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI EHRLICH, BARBARA E. · 1985 to 1994
–
MEMBRANE DYNAMICS OF LOCOMOTING TISSUE CELLSR01GM023585 · NIGMS · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI KOPPEL, DENNIS E · 1985 to 1995
–
STRUCTURAL MECHANISM &DRUG-CARDIAC MEMBRANE INTERACTIONR01HL032588 · NHLBI · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI HERBETTE, LEO G · 1985 to 1985
–
NHLBI NIH HHS HL-32588NHLBI NIH HHS HL-33026NIGMS NIH HHS GM-23585
6 · The paper itself

Abstract

A membrane bilayer pathway model has been proposed for the interaction of dihydropyridine (DHP) calcium channel antagonists with receptors in cardiac sarcolemma (Rhodes, D.G., J.G. Sarmiento, and L.G. Herbette. 1985. Mol. Pharmacol. 27:612-623) involving drug partition into the bilayer with subsequent receptor binding mediated (though probably not rate-limited) by diffusion within the bilayer. Recently, we have characterized the partition step, demonstrating that DHPs reside, on a time-average basis, near the bilayer hydrocarbon core/water interface. Drug distribution about this interface may define a plane of local concentration for lateral diffusion within the membrane. The studies presented herein examine the diffusional dynamics of an active rhodamine-labeled DHP and a fluorescent phospholipid analogue (DiIC16) in pure cardiac sarcolemmal lipid multibilayer preparations as a function of bilayer hydration. At maximal bilayer hydration, the drug diffuses over macroscopic distances within the bilayer at a rate identical to that of DiI (D = 3.8 X 10(-8) cm2/s), demonstrating the overall feasibility of the membrane diffusion model. The diffusion coefficients for both drug and lipid decreased substantially as the bilayers were dehydrated. While identical at maximal hydration, drug diffusion was significantly slower than that of DiIC16 in partially dehydrated bilayers, probably reflecting differences in mass distribution of these probes in the bilayer.

Indexed as

Lipid BilayersAnimalsDiffusionDogsFluorescent DyesHeartIon ChannelsMembrane LipidsMicroscopy, ElectronModels, BiologicalMolecular ConformationNitrendipineSarcolemmaX-Ray DiffractionFluorescent DyesIon ChannelsLipid BilayersMembrane LipidsNitrendipine

Identifiers

PMID2447967
PMCPMC1330101
OpenAlexW2033617373

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.